Spotlight -

Concierge Medicine Forum|

|Videos|October 12, 2021

Pros and Cons of Available Influenza Vaccines

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

Episodes in this series

Experts on Influenza

EP. 1 Evolving Influenza Trends Throughout COVID-19 Pandemic

Experts on Influenza

EP. 2 The Impact of Distancing, Masks, and Vaccination on Influenza

Experts on Influenza

EP. 3 Feasibility of Concurrent COVID-19 and Influenza Vaccination

Experts on Influenza

EP. 4 Similarities and Differences in COVID-19 and Influenza

Experts on Influenza

EP. 5 Identifying Patients at High Risk for Influenza Complications

Experts on Influenza

EP. 6 Pros and Cons of Available Influenza Vaccines

Experts on Influenza

EP. 7 Influenza Vaccination Timing and Reluctance

Experts on Influenza

EP. 8 Vaccination Misconceptions and Educating Patients

Experts on Influenza

EP. 9 Influenza Case 1: Female Patient With Asthma and Egg Allergy

Experts on Influenza

EP. 10 Influenza Case 2: Male Patient With Chronic Health Conditions

Charles Vega, MD, discusses the indications, administration requirements, dosing schedules, adverse events, and any contraindications that exist between each available influenza vaccines that is currently available.

Newsletter

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Medical Economics

Physicians have 5 responsibilities that AI will not replace: AMA

Are payors downcoding your evaluation and management services? Why every practice should be paying attention

Medical misinformation is eroding quality of care, trust between physicians and patients: Survey

Stop calling it ‘savings’: the real economics of closing Medicare care gaps

AI scribes fail to note patient experiences, U.K. review finds